MarketPeel
Insider Trading Intelligence
Pricing
…
OL

Orbimed Capital Gp Vii Llc

ELVN
DIRECTOR · ENLIVEN THERAPEUTICS, INC. · CIK 0001760648
FILING MIX · LIFETIME32%/68%
BUYS
55
SELLS
117
TOTAL VALUE
$232.50M
COMPANIES
9
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
19,643,431
AVG SELL PX
$16.60
TRADE KIND
SHOWING 172 / 172
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
64 backtested trades · 8 horizons · 37 pending
Forward-return performance of every backtestable P/S trade by Orbimed Capital Gp Vii Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d64+54.69%-2.95%-0.55%-2.40%-2.95%-1.96
14d64+53.13%-4.64%-0.57%-4.06%-5.24%-2.76
30d64+64.06%-11.66%-0.45%-11.21%-16.10%-6.22
60d64+48.44%-12.97%-0.52%-12.45%-11.42%-5.17
90d64+60.94%-17.05%-0.35%-16.70%-24.71%-5.73
180d64+62.50%-22.98%+1.86%-24.84%-39.22%-6.34
1y64+65.63%-11.49%+10.67%-22.16%-45.92%-2.26
2y64(37 pending)+37.04%-50.05%+20.77%-70.82%-65.21%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ELVN · 220,882 shares · as of Jun 22, 2026
02,165,8374,331,6756,497,5128,663,349202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 55 buys / 117 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
1,477$45.00$66.5K219,405Jun 22, 2026Jun 22, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
46,776$45.00$2.10M6,555,102Jun 22, 2026Jun 22, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
787,024$45.38$35.72M6,601,878Jun 22, 2026Jun 22, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
24,846$45.38$1.13M220,882Jun 22, 2026Jun 22, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
272,322$45.02$12.26M7,388,902Jun 15, 2026Jun 17, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
9,086$45.02$409.1K245,728Jun 15, 2026Jun 17, 2026 ↗View →
QTTB
Q32 BIO INC.
PURCHASE
1,250,000$8.00$10.00M3,502,987May 28, 2026Jun 1, 2026 ↗View →
QTTB
Q32 BIO INC.
PURCHASE
625,000$8.00$5.00M625,000May 28, 2026Jun 1, 2026 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
74,465$17.75$1.32M45,057Nov 21, 2025Dec 18, 2025 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
140,057$17.75$2.49M759,155Nov 21, 2025Dec 18, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
213,257$0.33$70.4K6,066,343Jun 26, 2025Jun 26, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
138,800$0.33$45.8K6,279,600Jun 25, 2025Jun 26, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
231,600$0.35$81.1K6,418,400Jun 24, 2025Jun 26, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
68,195$0.32$21.8K6,650,000Apr 24, 2025Apr 24, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
89,328$0.34$30.4K6,718,195Apr 23, 2025Apr 24, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
78,049$0.34$26.5K6,807,523Apr 22, 2025Apr 24, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
77,090$0.33$25.4K6,885,572Apr 17, 2025Apr 17, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
61,638$0.33$20.3K6,962,662Apr 16, 2025Apr 17, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
10,326$0.38$3.9K7,024,300Apr 15, 2025Apr 17, 2025 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
94,100$10.84$1.02M747,887Feb 18, 2025Feb 19, 2025 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
49,070$10.84$531.9K3,255,000Feb 18, 2025Feb 19, 2025 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
29,540$9.85$291.0K3,205,930Feb 14, 2025Feb 19, 2025 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
17,962$9.90$177.8K3,176,390Feb 14, 2025Feb 19, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
79,024$0.60$47.4K7,034,626Jan 14, 2025Jan 14, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
17,986$0.64$11.5K7,113,650Jan 13, 2025Jan 14, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
126,209$0.66$83.3K7,131,636Jan 10, 2025Jan 14, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
75,007$0.68$51.0K7,257,845Jan 8, 2025Jan 8, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
52,536$0.71$37.3K7,332,852Jan 7, 2025Jan 8, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
19,481$0.77$15.0K7,385,388Jan 6, 2025Jan 8, 2025 ↗View →
PASG
PASSAGE BIO, INC.
SALE
230,321$0.60$138.2K7,404,869Dec 20, 2024Dec 26, 2024 ↗View →
PASG
PASSAGE BIO, INC.
SALE
80$0.80$647,635,190Dec 11, 2024Dec 11, 2024 ↗View →
PASG
PASSAGE BIO, INC.
SALE
8,015$0.80$6.4K7,635,270Dec 10, 2024Dec 11, 2024 ↗View →
PASG
PASSAGE BIO, INC.
SALE
54,181$0.84$45.5K7,643,285Dec 9, 2024Dec 11, 2024 ↗View →
PASG
PASSAGE BIO, INC.
SALE
20,903$0.82$17.1K7,697,466Dec 6, 2024Dec 6, 2024 ↗View →
PASG
PASSAGE BIO, INC.
SALE
76,200$0.79$60.2K7,718,369Dec 4, 2024Dec 6, 2024 ↗View →
PASG
PASSAGE BIO, INC.
SALE
39,300$0.71$27.9K7,794,569Sep 19, 2024Sep 23, 2024 ↗View →
PASG
PASSAGE BIO, INC.
SALE
25,631$0.73$18.7K7,833,869Sep 18, 2024Sep 18, 2024 ↗View →
PASG
PASSAGE BIO, INC.
SALE
111,400$0.73$81.3K7,859,500Sep 17, 2024Sep 18, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
SALE
19,587,284——0Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
2,658,428——2,658,428Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
500,000$16.00$8.00M3,158,428Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
SALE
12,372,634——0Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
SALE
4,854,368——0Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
403,787——403,787Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
250,000$16.00$4.00M653,787Sep 16, 2024Sep 17, 2024 ↗View →
PASG
PASSAGE BIO, INC.
SALE
63,100$0.74$46.7K7,970,900Sep 16, 2024Sep 18, 2024 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
220,600$44.01$9.71M899,212Aug 13, 2024Aug 15, 2024 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
29,400$44.01$1.29M119,522Aug 13, 2024Aug 15, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
556$10.00$5.6K1,967,924Jul 16, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
623$10.00$6.2K755,635Jul 16, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,009$10.00$40.1K4,839,412Jul 16, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
39,433$10.00$394.3K4,843,421Jul 15, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,401$10.00$54.0K1,968,480Jul 15, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,142$10.00$61.4K756,258Jul 15, 2024Jul 17, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
33,300$22.14$737.3K254,814May 16, 2024May 20, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
1,000,000$22.14$22.14M7,663,349May 16, 2024May 20, 2024 ↗View →
GLTO
GALECTO, INC.
SALE
248,819$0.75$186.6K631,048Aug 15, 2023Aug 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
535,534$0.75$401.7K1,510,375Aug 15, 2023Aug 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
38,327$0.75$28.7K97,204Aug 15, 2023Aug 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
29,700$3.00$89.1K879,867Jul 31, 2023Aug 2, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
153,078$3.00$459.2K2,105,909Jul 31, 2023Aug 2, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
26,622$3.00$79.9K135,531Jul 31, 2023Aug 2, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
7,800$2.92$22.8K162,153Jul 25, 2023Jul 27, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
4,700$2.92$13.7K909,567Jul 25, 2023Jul 27, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
26,700$2.92$78.0K2,258,987Jul 25, 2023Jul 27, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
52,800$2.40$126.7K914,267Jul 13, 2023Jul 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
9,800$2.40$23.5K169,953Jul 13, 2023Jul 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
132,100$2.40$317.0K2,285,687Jul 13, 2023Jul 17, 2023 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
575,195$0.84$483.2K8,034,000Jun 28, 2023Jun 29, 2023 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
617,382$0.84$518.6K7,458,805Jun 27, 2023Jun 29, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASE
2,125$4.28$9.1K8,663,349May 17, 2023May 19, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
2,125——0May 17, 2023May 19, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
3,551$1.97$7.0K967,067Apr 17, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
8,878$1.97$17.5K2,417,787Apr 17, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
660$1.97$1.3K179,753Apr 17, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
11,245$1.86$20.9K970,618Apr 14, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
2,091$1.86$3.9K180,413Apr 14, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
28,110$1.86$52.3K2,426,665Apr 14, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
703$1.82$1.3K182,504Apr 13, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
3,784$1.82$6.9K981,863Apr 13, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
9,459$1.82$17.2K2,454,775Apr 13, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
119$1.81$215183,207Apr 12, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
1,603$1.81$2.9K2,464,234Apr 12, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
641$1.81$1.2K985,647Apr 12, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
703$1.82$1.3K183,326Apr 11, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
9,459$1.82$17.2K2,465,837Apr 11, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
3,784$1.82$6.9K986,288Apr 11, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
34,745$1.79$62.2K2,500,582Apr 10, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
2,584$1.79$4.6K185,910Apr 10, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
13,899$1.79$24.9K1,000,187Apr 10, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
6,558$2.00$13.1K2,510,041Apr 6, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
2,620$2.00$5.2K1,003,971Apr 6, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
487$2.00$974186,613Apr 6, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
25,220$2.18$55.0K1,006,591Apr 5, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
4,687$2.18$10.2K187,100Apr 5, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
63,058$2.18$137.5K2,516,599Apr 5, 2023Apr 7, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
288,114——288,114Feb 23, 2023Feb 27, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,611,458——8,661,225Feb 23, 2023Feb 27, 2023 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
137,931$7.25$1000.0K4,882,854Dec 23, 2022Dec 28, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
457,400$2.42$1.11M1,973,881Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
207,500——207,500Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
64,050——64,050Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
2,470,200$2.42$5.98M4,744,923Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
38,450——38,450Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
762,400$2.42$1.85M762,400Aug 16, 2022Aug 18, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
35,944$21.31$766.0K415,142Jun 24, 2022Jun 28, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
306,027$21.31$6.52M3,534,537Jun 24, 2022Jun 28, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
303,500$1.94$588.8K6,841,423May 4, 2022May 5, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
221,500$1.93$427.5K6,537,923May 3, 2022May 5, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
102,800$20.71$2.13M451,086Apr 8, 2022Apr 8, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
97,200$20.71$2.01M3,840,564Apr 8, 2022Apr 8, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
167,800$20.66$3.47M3,937,764Apr 7, 2022Apr 8, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
177,196$20.66$3.66M553,886Apr 7, 2022Apr 8, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
171,204$20.69$3.54M731,082Apr 6, 2022Apr 8, 2022 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
162,000$20.69$3.35M4,105,564Apr 6, 2022Apr 8, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
369,100$5.42$2.00M6,634,723Jan 20, 2022Jan 24, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
50,800$5.00$254.0K6,316,423Jan 20, 2022May 5, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
43,300$5.11$221.3K6,265,623Jan 19, 2022Jan 20, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
114,700$5.46$626.3K6,222,323Jan 18, 2022Jan 20, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
10,300$5.60$57.7K6,107,623Jan 14, 2022Jan 20, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
41,800$5.52$230.7K6,097,323Jan 13, 2022Jan 13, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
100,000$5.65$565.0K6,055,523Jan 12, 2022Jan 13, 2022 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
8,200$5.53$45.3K5,955,523Jan 11, 2022Jan 13, 2022 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
356,800$19.07$6.80M2,403,566Dec 16, 2021Dec 17, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
36,500$19.07$696.1K245,898Dec 16, 2021Dec 17, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
918,295——0Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
285,000$17.00$4.84M2,274,723Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
612,196——0Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,989,723——1,989,723Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
190,000$17.00$3.23M1,516,481Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,326,481——1,326,481Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
714,285——0Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
1,071,428——0Feb 9, 2021Feb 9, 2021 ↗View →
GLTO
GALECTO, INC.
PURCHASE
191,787——191,787Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
109,013——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
291,999——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
PURCHASE
523,833$15.00$7.86M2,579,657Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
PURCHASE
209,500$15.00$3.14M1,031,811Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
PURCHASE
822,311——822,311Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
148,395——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
116,800——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
PURCHASE
2,055,824——2,055,824Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
77,866——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
73,773——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
272,533——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
31,147——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
59,350——0Nov 2, 2020Nov 4, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
296,000$25.00$7.40M902,286Oct 2, 2020Oct 6, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
200,000$25.00$5.00M4,267,564Oct 2, 2020Oct 6, 2020 ↗View →
GLTO
GALECTO, INC.
SALEGRANT
Stock grant
59,350$27.11$1.61M59,350Sep 25, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALEGRANT
Stock grant
73,773$27.11$2.00M73,773Sep 25, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALEGRANT
Stock grant
148,395$27.11$4.02M148,395Sep 25, 2020Nov 4, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
148,922——0Apr 13, 2020Apr 13, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
375,200$16.00$6.00M1,119,812Apr 13, 2020Apr 13, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
744,612——0Apr 13, 2020Apr 13, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
148,922——148,922Apr 13, 2020Apr 13, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
744,612——744,612Apr 13, 2020Apr 13, 2020 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
541,002——5,947,323Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
SALE
1,311,469——0Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
SALE
3,721,552——0Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
1,311,469——5,406,321Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
SALE
541,002——0Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
3,721,552——4,094,852Mar 3, 2020Mar 3, 2020 ↗View →
PASG
PASSAGE BIO, INC.
PURCHASE
373,300$18.00$6.72M373,300Feb 28, 2020Mar 3, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
429,786——0Feb 4, 2020Feb 4, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
859,573——4,067,564Feb 4, 2020Feb 4, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
429,786——606,286Feb 4, 2020Feb 4, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
859,573——0Feb 4, 2020Feb 4, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
SALE
2,825,603——0Feb 4, 2020Feb 4, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
2,825,603——3,207,991Feb 4, 2020Feb 4, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
382,388$17.00$6.50M382,388Feb 3, 2020Feb 4, 2020 ↗View →
ARQT
ARCUTIS BIOTHERAPEUTICS, INC.
PURCHASE
176,500$17.00$3.00M176,500Feb 3, 2020Feb 4, 2020 ↗View →
Other insiders · ELVN
Loading peer insiders…
About this filer
CIK 0001760648
ROLE
Director
PRIMARY
ELVN
COMPANIES
9
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001760648DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback